Ara
Toplam kayıt 34, listelenen: 11-20
Monitoring The Response To Tyrosine Kinase Inhibitor (Tki) Treatment In Chronic Myeloid Leukemia (Cml)
(2014)
The aim of oral tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) is to get ideal hematological, cytogenetic, molecular responses at the critical time points. The depth of the response obtained ...
Ankaferd Blood Stopper Is More Effective Than Adrenaline Plus Lidocaine And Gelatin Foam In The Treatment Of Epistaxis In Rabbits
(Elsevier Science Inc, 2011)
BACKGROUND: Epistaxis is an important emergency that can sometimes be life threatening without effective intervention. Persistent and recurrent bleeding can lead to aspiration, hypotension, hypoxia, or even severe and ...
A New Candidate As a Hemostatic Agent For Difficult Situations During Variceal Bleeding: Ankaferd Blood Stopper
(2011)
Variceal bleeding is the most challenging emergent situation among the causes of upper gastrointestinal bleeding. Despite substantial improvement, a need remains for therapeutic armamentarium of such cases, which is easy, ...
Do All Hemolytic Anemias That Occur After Mitral Valve Repair Require Surgical Treatment?
(Wiley, 2010)
We report on a 29-year-old woman with severe hemolytic anemia following mitral valve annuloplasty. Although hemolysis due to mechanical prosthetic mitral valve is well recognized, hemolytic anemia associated with mitral ...
Local Bone Marrow Renin-Angiotensin System and Atherosclerosis
(2010)
Local hematopoietic bone marrow (BM) renin-angiotensin system (RAS) affects the growth, production, proliferation differentiation, and function of hematopoietic cells. Angiotensin II (Ang II), the dominant effector peptide ...
Prohemostatic and Antithrombin Activities of Ankaferd Hemostat are Linked To Fibrinogen Gamma Chain and Prothrombin by Functional Proteomic Analyses
(Sage Publications Inc, 2012)
Ankaferd blood stopper (ABS) is a novel topical hemostatic agent of plant origin registered for the management of external hemorrhages, in Turkey. The ABS-induced formation of the protein network with vital erythroid ...
Functional Proteomic Analysis Of Ankaferd (R) Blood Stopper
(Aves Yayincilik, 2010)
Objective: Ankaferd (R) Blood Stopper (ABS) comprises a standardized mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica. The basic mechanism of action for ABS ...
In Vivo Healing Effects Of Ankaferd Blood Stopper On The Residual Pancreatic Tissue In A Swine Model Of Distal Pancreatectomy
(Springer India, 2015)
The aim of this study was to determine whether intraoperative Ankaferd blood stopper (ABS) application into the pancreatic channel and to the pancreatic remnant surface following distal pancreatectomy can or cannot prevent ...
Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids
(2016)
Introduction. Ankaferd hemostat (ABS) is the first topical haemostatic agent involving the red blood cell-fibrinogen interactions. The antihemorrhagic efficacy of ABS has been tested in controlled clinical trials. The drug ...
The Impact Of Jak1/Jak2 Inhibitor Ruxolitinib On The Spleen Size And Symptom Burden In Myeloproliferative Diseases
(Akad Doktorlar Yayınevi, 2016)
Ruxolitinib as a JAK1 and JAK2 inhibitor drug has recently been approved for the treatment of patients with high-or intermediate-risk myelofibrosis with symptomatic splenomegaly. Clinical development of ruxolitinib has ...